LEADER 01322nas  2200445-  450 
001 996321235803316
005 20230223213019.0
011   $a2516-4236
035   $a(DE-599)ZDB3031893-2
035   $a(OCoLC)1077386114
035   $a(CKB)4100000007005805
035   $a(CONSER)--2020243009
035   $a(EXLCZ)994100000007005805
100   $a20180720a20189999  o--            -
101 0 $aeng
135   $aur|||||||||||
181   $ctxt$2rdacontent
182   $cc$2rdamedia
183   $acr$2rdacarrier
200 00$aAntibody therapeutics
210  1$a[New York] :$cOxford University Press,$d[2018]-
215   $a1 online resource
300   $aRefereed/Peer-reviewed
531 10$aAntib Ther
606   $aImmunoglobulins$xTherapeutic use
606   $aAntibodies$xtherapeutic use
606   $aImmunologic Factors
606   $aImmunoglobulins$xTherapeutic use$2fast$3(OCoLC)fst00967968
608   $aPeriodicals.$2lcgft
608   $aPeriodical.
608   $aPeriodicals.$2fast
615  0$aImmunoglobulins$xTherapeutic use.
615  2$aAntibodies$xtherapeutic use.
615 22$aImmunologic Factors.
615  7$aImmunoglobulins$xTherapeutic use.
676   $a615
906   $aJOURNAL
912   $a996321235803316
996   $aAntibody therapeutics$92280195
997   $aUNISA